Use of Molecular Genetic Analyses in Danish Routine Newborn Screening
| العنوان: | Use of Molecular Genetic Analyses in Danish Routine Newborn Screening |
|---|---|
| المؤلفون: | Marie Bækvad-Hansen, Flemming Wibrand, Rikke Katrine Jentoft Olsen, David M. Hougaard, Kristin Skogstrand, Allan M. Lund, Morten Duno, Niels Gregersen, Brage S. Andresen |
| المصدر: | International Journal of Neonatal Screening, Vol 7, Iss 50, p 50 (2021) International Journal of Neonatal Screening Lund, A M, Wibrand, F, Skogstrand, K, Bækvad-Hansen, M, Gregersen, N, Andresen, B S, Hougaard, D M, Dunø, M & Olsen, R K J 2021, ' Use of molecular genetic analyses in danish routine newborn screening ', International Journal of Neonatal Screening, vol. 7, no. 3, 50 . https://doi.org/10.3390/IJNS7030050 Volume 7 Issue 3 |
| بيانات النشر: | MDPI AG, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | Newborn screening, 0301 basic medicine, Tandem mass spectrometry, Computer science, Population, Computational biology, 030105 genetics & heredity, second-tier test, Pediatrics, Article, RJ1-570, 03 medical and health sciences, 0302 clinical medicine, Immunology and Microbiology (miscellaneous), Targeted ngs, Next generation sequencing, tandem mass spectrometry, neonatal screening, education, Therapeutic strategy, next generation sequencing, First-tier test, education.field_of_study, newborn screening, Molecular genetic testing, Obstetrics and Gynecology, food and beverages, Second-tier test, Biomarker (cell), Workflow, first-tier test, Pediatrics, Perinatology and Child Health, embryonic structures, False positive rate, Neonatal screening, 030217 neurology & neurosurgery |
| الوصف: | Historically, the analyses used for newborn screening (NBS) were biochemical, but increasingly, molecular genetic analyses are being introduced in the workflow. We describe the application of molecular genetic analyses in the Danish NBS programme and show that second-tier molecular genetic testing is useful to reduce the false positive rate while simultaneously providing information about the precise molecular genetic variant and thus informing therapeutic strategy and easing providing information to parents. When molecular genetic analyses are applied as second-tier testing, valuable functional data from biochemical methods are available and in our view, such targeted NGS technology should be implemented when possible in the NBS workflow. First-tier NGS technology may be a promising future possibility for disorders without a reliable biomarker and as a general approach to increase the adaptability of NBS for a broader range of genetic diseases, which is important in the current landscape of quickly evolving new therapeutic possibilities. However, studies on feasibility, sensitivity, and specificity are needed as well as more insight into what views the general population has towards using genetic analyses in NBS. This may be sensitive to some and could have potentially negative consequences for the NBS programme. |
| وصف الملف: | application/pdf |
| اللغة: | English |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::028e16b2c4c83805efa15bcf63e1a9ad https://www.mdpi.com/2409-515X/7/3/50 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....028e16b2c4c83805efa15bcf63e1a9ad |
| قاعدة البيانات: | OpenAIRE |
| الوصف غير متاح. |